ATE402258T1 - Gene differentiell experimiert in brudtkrebs - Google Patents

Gene differentiell experimiert in brudtkrebs

Info

Publication number
ATE402258T1
ATE402258T1 AT01942365T AT01942365T ATE402258T1 AT E402258 T1 ATE402258 T1 AT E402258T1 AT 01942365 T AT01942365 T AT 01942365T AT 01942365 T AT01942365 T AT 01942365T AT E402258 T1 ATE402258 T1 AT E402258T1
Authority
AT
Austria
Prior art keywords
experimented
major cancer
gene differential
seq
cancer cells
Prior art date
Application number
AT01942365T
Other languages
German (de)
English (en)
Inventor
Joerg Kaufmann
Greg Harrowe
Christoph Reinhard
Sanmao Kang
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE402258T1 publication Critical patent/ATE402258T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01942365T 2000-01-10 2001-01-09 Gene differentiell experimiert in brudtkrebs ATE402258T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17546200P 2000-01-10 2000-01-10

Publications (1)

Publication Number Publication Date
ATE402258T1 true ATE402258T1 (de) 2008-08-15

Family

ID=22640304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942365T ATE402258T1 (de) 2000-01-10 2001-01-09 Gene differentiell experimiert in brudtkrebs

Country Status (9)

Country Link
US (1) US7605246B2 (enExample)
EP (2) EP1985701B1 (enExample)
JP (2) JP5250168B2 (enExample)
AT (1) ATE402258T1 (enExample)
AU (1) AU2001229367A1 (enExample)
DE (1) DE60134956D1 (enExample)
ES (2) ES2311016T3 (enExample)
PT (1) PT1248841E (enExample)
WO (1) WO2001051515A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081517B2 (en) * 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
DE102011110592A1 (de) 2011-08-18 2013-02-21 Rena Gmbh Verfahren zum Konditionieren von flachen Gegenständen
CN112837822B (zh) * 2020-09-24 2023-05-02 广州市疾病预防控制中心(广州市卫生检验中心、广州市食品安全风险监测与评估中心、广州医科大学公共卫生研究院) 预测covid-19患者发生轻至重度进展的标志物及试剂盒和建立方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
IE58011B1 (en) 1983-05-27 1993-06-16 Texas A & M Univ Sys Method for producing a recombinant baculovirus expression vector
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
IL77186A0 (en) 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
IT1254309B (it) 1992-02-17 1995-09-14 Uni Degli Studi G D Annunzio C Sequenze genetiche per l'antigene 90k associato a tumori.
EP0616802B1 (en) 1992-08-13 1998-06-17 Teikoku Seiyaku Co., Ltd. Oral preparation for release in lower digestive tracts
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2003514543A (ja) * 1999-11-19 2003-04-22 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 23個のヒト分泌タンパク質

Also Published As

Publication number Publication date
JP5250168B2 (ja) 2013-07-31
US7605246B2 (en) 2009-10-20
JP2003519480A (ja) 2003-06-24
JP2012143242A (ja) 2012-08-02
ES2311016T3 (es) 2009-02-01
EP1985701A2 (en) 2008-10-29
EP1985701A3 (en) 2009-01-07
ES2386317T3 (es) 2012-08-17
DE60134956D1 (de) 2008-09-04
WO2001051515A2 (en) 2001-07-19
US20020004239A1 (en) 2002-01-10
EP1248841A2 (en) 2002-10-16
EP1248841B1 (en) 2008-07-23
EP1985701B1 (en) 2012-05-30
HK1118861A1 (en) 2009-02-20
WO2001051515A3 (en) 2002-01-24
PT1248841E (pt) 2008-09-15
AU2001229367A1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ATE386804T1 (de) Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
AU1726199A (en) Metastatic cancer regulated gene
ATE190313T1 (de) Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
TR200003685T1 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin
DK3059322T3 (da) Genekspressionsmarkører for brystcancerprognose
ATE422536T1 (de) Zusammensetzungen und methoden zur diagnose von tumoren
EP1242060A4 (en) TREATMENT OF METASTATIC DISEASES
WO1999014327A3 (en) Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
DK1082341T3 (da) Anvendeligt tumorantigen i diagnose og behandling af prostata- og koloncancer
KR100517848B1 (en) Compositions and Methods for The Treatment of Tumor
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
ATE402258T1 (de) Gene differentiell experimiert in brudtkrebs
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
DE69837935D1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
EP1693457A3 (en) Metastatic breast and colon cancer regulated genes
WO1999043812A3 (en) Dlc-1 gene, a putative tumors suppressor gene
WO2002042460A3 (en) Compositions and methods relating to colon specific genes and proteins
ATE391176T1 (de) Neues gen mit induzierter expression in menschlichen metastatischen tumorzellen
WO2002036807A3 (en) Compositions and methods relating to breast specific genes and proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties